[1]
B. T., R. K. R., A. C. R., A. P., D. S., and J. R., “Effect of casirivimab-imdevimab on mild COVID-19 patients with diabetes in reducing oxygen supplementation at 28 days: an observational study”, Int J Res Med Sci, vol. 10, no. 9, pp. 1983–1987, Aug. 2022.